Document type
ArticleVersion
Published versionPublication date
Publication license
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/110767
Ivermectin to reduce malaria transmission III. Considerations regarding regulatory and policy pathways
Journal Title
Authors
Director/Tutor
Journal ISSN
Volume Title
Related resource
Abstract
Vector control is a task previously relegated to products that
(a) kill the mosquitoes directly at different stages
(insecticides, larvicides, baited traps), or (b) avoid/reduce
human-mosquito contact (bed nets, repellents, house screening),
thereby reducing transmission. The potential community-based
administration of the endectocide ivermectin with the intent to
kill mosquitoes that bite humans, and thus reduce malaria
transmission, offers a novel approach using a well-known drug,
but additional steps are required to address technical,
regulatory and policy gaps. The proposed community
administration of this drug presents dual novel paradigms;
first, indirect impact on the community rather than on
individuals, and second, the use of a drug for vector control.
In this paper, the main questions related to the regulatory and
policy pathways for such an application are identified. Succinct
answers are proposed for how the efficacy, safety,
acceptability, cost-effectiveness and programmatic suitability
could result in regulatory approval and ultimately policy
recommendations on the use of ivermectin as a complementary
vector control tool.
Subject
Subject (English)
Citation
Collections
Citation
CHACCOUR, Carlos and RABINOVICH, Regina. Ivermectin to reduce malaria transmission III. Considerations
regarding regulatory and policy pathways. Malaria Journal. 2017. Vol. 16, num. 1, pags. 162. ISSN 1475-2875. [consulted: 18 of August of 2026]. Available at: https://hdl.handle.net/2445/110767